Navigation Links
Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
Date:1/25/2011

ysiology business; Vistakon's disposable contact lenses; and Ortho-Clinical Diagnostics' products. This growth was partially offset by lower sales in the Cordis franchise, reflecting continued market and competitive pressures in the drug-eluting stent market.

During the quarter, the Company submitted a Biologic License Application to the FDA for the Fibrin Pad, a novel product that combines Ethicon's biomaterials and plasma-derived biologics (Human Fibrinogen and Human Thrombin), to aid in stopping soft tissue bleeding during surgery. In addition, the Company received CE Mark for OneTouch® Verio®Pro, a system for self monitoring of blood glucose levels.

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our 114,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

* Net earnings and diluted earnings per share excluding special items, such as after-tax restructuring charges, the net impact of litigation settlements, product liability expense and costs associated with the DePuy ASR® Hip recall, are non-GAAP financial measures and should not be considered replacements for GAAP results. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the Investor Relations section of the Company's website at www.investor.jnj.com.

NOTE TO INVESTORS

Johnson & Johnson will conduct a meeting with members of the investment community to discuss this news release today at 8:30 a.m., Eastern Time. A simultaneous webcast of the meeting for investors and other interested parties may be acce
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
2. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
3. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
4. Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
5. Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
6. Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business
7. Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His Notoriety in New ExtenZe Spots from Inter/Media Advertising
8. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
9. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
10. Johnson & Johnson Completes Acquisition of Micrus Endovascular
11. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 OmPrompt ... Millionen £ investiert hat, um die weltweite ... Pharma- und Logistikbranche zu erfüllen. Albion wird ... (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ) ... sein beschleunigtes Wachstum mit Investitionen in seine ...
(Date:7/28/2014)... VILLAGE, Nev. , July 28, 2014 PDL ... that the Company will release its second quarter 2014 financial ... August 11, 2014, after market close. PDL,s management will host ... Eastern Time to discuss the financial results.  A slide presentation ... link on the PDL website. Conference Call Details ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize companion ... the use of IRESSA  for non-small cell lung cancer ... QIAGEN,s FDA-approved  therascreen   EGFR test and is planned to run on ... instruments  Project enabled by AstraZeneca master framework ...
Breaking Medicine Technology:OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
... Consumer Healthcare Products Association (CHPA) released the following ... passing a real-time, stop-sale system that allows law-abiding ... pseudoephedrine (PSE), while stopping sales that exceed the ... real-time, stop-sale system is a victory for law-abiding ...
... HeartWare International, Inc. (NASDAQ: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to make an investor presentation at ... Eastern Time on Wednesday, June 22, 2011.  The conference ...
Cached Medicine Technology:HeartWare to Present at the Wells Fargo 2011 Healthcare Conference 2
(Date:7/28/2014)... new study, published in the July, 2014, issue ... Institute by Northwestern Medicine researchers, sheds new ... popularity of endoscopic resection in the treatment of ... more traditional surgical resection, while more invasive, provided ... survival rate for patients than endoscopic resection, which ...
(Date:7/28/2014)... Smart phones and mobile devices are on the cusp ... apps capable of providing everything from cardiac measurements to ... to medical treatment and control costs, several health law ... of Medicine (NEJM) report that more oversight is ... to ensure consumer confidence and safety. Out of some ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 A young ... to the all-too-often stories in the media today about ... occur in a matter of minutes in a hot ... to the Office of Emergency Medical Services at NHTSA. ... app for smartphones. Realizing that it’s all too easy ...
(Date:7/28/2014)... Abington, PA (PRWEB) July 28, 2014 ... solutions provider for the healthcare industry, went live in ... and surpassed the basic standards of excellence that comprise ... specifically for excellence in Healthcare. , “What pleases me ... both the content and usability categories,” said Joshua Snow, ...
(Date:7/28/2014)... 2014 Irresistible infants have met their match with ... The online gifting company specializes in homemade chicken noodle soup and ... Baby package starts with home-from-the-hospital essentials every new parent will love:, ... 6 rolls , 6 cookies , a ... is ready to heat and eat upon delivery, so parents can ...
Breaking Medicine News(10 mins):Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Abington Health Website Named Best in Class 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... genetic links, but urge further study , WEDNESDAY, Oct. ... that might be associated with autism have been identified ... a single-letter change on chromosome 5 near a gene ... the growth of neurons and their long progressions, called ...
... 7 Each year, an estimated 800,000 ... in which the victims survive, but their lives, and ... Brain injury victims can suffer from a multitude of ... depression and sleep disturbances. , Careforward , ...
... Crawford & Company,s (NYSE: CRDA ; CRDB) ... under the brand name of Broadspire, a Crawford company, ... , Crawford (NYSE: CRDA ; CRDB), the world,s ... latest expansion of the Broadspire brand at the Federation ...
... Healthcare, one of the nation,s first and leading providers ... nephrology research, today announced their sponsorship of the National ... , The Author,s Luncheon is San Francisco,s premier ... captivated by the fascinating stories, wit and humor of ...
... , BOCA RATON, Fla., Oct. 7 Coverall Health-Based Cleaning ... announced it has been recognized as one of the ... Franchising Initiative (NMFI) for the third year in a ... "Franchising Today" section of USA Today, the national daily ...
... Henry Ford Hospital have identified tumor-suppressing genes that may ... survival for laryngeal cancer patients than current standards. ... specific receptor 1) gene and the HIC1 (hypermethylated in ... and shorter survival, respectively, for patients with the disease. ...
Cached Medicine News:Health News:Potential Pieces of Autism Puzzle Revealed 2Health News:Mingling, Martinis & Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 2Health News:Crawford & Company's Broadspire Unit Continues Its European Expansion 2Health News:Satellite Healthcare Partners With the National Kidney Foundation for the 21st Annual San Francisco Author's Luncheon 2Health News:Coverall Named Among '50 Top Franchises for Minorities' for Third Consecutive Year 2Health News:Genes signal late-stage laryngeal cancer, poorer outcome 2
... The Finnpipette Digital Multichannel, ... even lighter work of routine ... all these advanced features: Soft-touch ... micro volume pipetting (0.5-10ul models), ...
... Unique to the Medtronic Hall, the aortic and ... In the aortic position, the disc opens to ... valve opens to 70 to minimize regurgitation. Designed ... the surgeon to align the leading edge of ...
... Pipettor , , The Shortyavailable with both ... how our face-to-face relationship with the scientific community ... make pipetting easier and more effective., Shorter ... Gets you closer to the working area ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: